Skip to main content
Top

2023 | OriginalPaper | Chapter

A Time Study for the Analysis of the Potential for the Automated Stepwise Screening Program for Preeclampsia at Week 12 of Gestation

Authors : Louise Pedersen, Stefan Wagner, Henriette Skov, Puk Sandager

Published in: ICT for Health, Accessibility and Wellbeing

Publisher: Springer Nature Switzerland

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

Preeclampsia (PE) is a hypertensive disorder of pregnancy, occurring in 2–8% of all pregnancies. PE can cause life-threatening conditions and result in adverse events for both mother and baby. The only treatment of the condition is delivery of the baby, which often leads to preterm delivery. It is shown that prophylactic treatment with aspirin from early pregnancy can prevent or delay severe preeclampsia in women with high risk of PE. Screening by a combination of maternal risk factors and biomarkers has been shown to identify up to 90% of women at risk of developing early-onset PE. The aim of this study was to investigate the time spent for each step in the screening program in the first-trimester screening program in week 12 as input for an analysis of the potential for the automated stepwise screening program. The time used for obtaining maternal risk factors (MF), mean arterial blood pressure (MAP), and uterine arterial pulsatility index (UtA-PI) was measured through observations and using dedicated timekeeper tablet apps. The study found that the mean duration for measuring the UtA-PI was 2.7 min ranging from 1.3–8.5 min, based on 39 participants. In addition, there was no significant time difference (p = 0.4, effect size = 0.2) in answering the questions on MF by using a self-reported digital questionnaire compared to being interviewed by a healthcare professional, based on 18 and 14 participants, in each group. There was significant difference in the time spent for placement of the blood pressure (BP) cuffs when done by a healthcare professional compared to the participants doing it themselves, (p < 0.001, effect size = 0.8), based on 32 participants, where participants would be slower than the healthcare professional. In conclusion, we found that if a screening programme for PE is introduced, the duration for the first trimester ultrasound scan should be extended by 5 min to include the UtA-PI measurement. Also, guidance is needed to assist the woman or her partner to choose and place the BP cuffs correctly, otherwise it could require extra staff resources. Finally, the participants are likely to be able to self-report MF using a tablet user interface.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Literature
1.
go back to reference Duley, L.: The global impact of pre-eclampsia and eclampsia. Semin. Perinatol. 33(3), 130–137 (2009) Duley, L.: The global impact of pre-eclampsia and eclampsia. Semin. Perinatol. 33(3), 130–137 (2009)
2.
go back to reference Poon, L.C., Magee, L.A., Verlohren, S., Nicolaides, K.H., Shennan, A., Dadelszen, P.V., et al.: A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre-eclampsia. Int. J. Gynecol. Obstet. 154(S1), 3–31 (2021) Poon, L.C., Magee, L.A., Verlohren, S., Nicolaides, K.H., Shennan, A., Dadelszen, P.V., et al.: A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre-eclampsia. Int. J. Gynecol. Obstet. 154(S1), 3–31 (2021)
3.
go back to reference Poon, L.C., Shennan, A., Hyett, J.A., Kapur, A., Hadar, E., Divakar, H., et al.: The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention. Int. J. Gynecol. Obstet. 145(suppl. 1), 1–33 (2019) Poon, L.C., Shennan, A., Hyett, J.A., Kapur, A., Hadar, E., Divakar, H., et al.: The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention. Int. J. Gynecol. Obstet. 145(suppl. 1), 1–33 (2019)
4.
go back to reference Rolnik, D.L., et al.: Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N. Engl. J. Med. 377(7), 613–622 (2017) Rolnik, D.L., et al.: Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N. Engl. J. Med. 377(7), 613–622 (2017)
5.
go back to reference Van Doorn, R., Mukhtarova, N., Flyke, I.P., Lasarev, M., Kim, K., Hennekens, C.H., et al.: Dose of aspirin to prevent preterm preeclampsia in women with moderate or high-risk factors: a systematic review and meta-analysis. PLOS ONE 16(3) (2021) Van Doorn, R., Mukhtarova, N., Flyke, I.P., Lasarev, M., Kim, K., Hennekens, C.H., et al.: Dose of aspirin to prevent preterm preeclampsia in women with moderate or high-risk factors: a systematic review and meta-analysis. PLOS ONE 16(3) (2021)
6.
go back to reference Sonek, J., Krantz, D., Carmichael, J., Downing, C., Jessup, K., Haidar, Z., et al.: First-trimester screening for early and late preeclampsia using maternal characteristics, biomarkers, and estimated placental volume. Am. J. Obstet. Gyneocol. 218(1), 126.E1–126.E13 (2017) Sonek, J., Krantz, D., Carmichael, J., Downing, C., Jessup, K., Haidar, Z., et al.: First-trimester screening for early and late preeclampsia using maternal characteristics, biomarkers, and estimated placental volume. Am. J. Obstet. Gyneocol. 218(1), 126.E1–126.E13 (2017)
7.
go back to reference Garcia, A.D., Devlieger, R., Redekop, K., Vandeweyer, K., Verlohren, S., Poon, L.C.: Cost-utility of a first-trimester screening strategy versus the standard of care for nulliparous women to prevent pre-term pre-eclampsia in Belgium. Pregnancy Hypertens. Int. J. Womens Cardiovasc. Health 25, 219–224 (2021) Garcia, A.D., Devlieger, R., Redekop, K., Vandeweyer, K., Verlohren, S., Poon, L.C.: Cost-utility of a first-trimester screening strategy versus the standard of care for nulliparous women to prevent pre-term pre-eclampsia in Belgium. Pregnancy Hypertens. Int. J. Womens Cardiovasc. Health 25, 219–224 (2021)
8.
go back to reference Zhong, Y., Tuuli, M., Odibo, A.O.: First-trimester assessment of placenta function and the prediction of preeclampsia and intrauterine growth restriction. Prenat. Diagn. 30, 293–308 (2010)CrossRef Zhong, Y., Tuuli, M., Odibo, A.O.: First-trimester assessment of placenta function and the prediction of preeclampsia and intrauterine growth restriction. Prenat. Diagn. 30, 293–308 (2010)CrossRef
9.
go back to reference Wright, D., Wright, A., Nicolaides, K.H.: The competing risk approach for prediction of preeclampsia. Am. J. Obstet. Gyneocol. 223(1), 12–23 (2020)CrossRef Wright, D., Wright, A., Nicolaides, K.H.: The competing risk approach for prediction of preeclampsia. Am. J. Obstet. Gyneocol. 223(1), 12–23 (2020)CrossRef
10.
go back to reference O’Gorman, N., Wright, D., Syngelaki, A., Akolekar, R., Wright, A., Poon, L.C., et al.: Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11–13 weeks gestation. Am. J. Obstet. Gyneocol. 214(1), 103.E1–103.E12 (2016) O’Gorman, N., Wright, D., Syngelaki, A., Akolekar, R., Wright, A., Poon, L.C., et al.: Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11–13 weeks gestation. Am. J. Obstet. Gyneocol. 214(1), 103.E1–103.E12 (2016)
11.
go back to reference Akolekar, R., Syngelaki, A., Sarquis, R., Zvanca, M., Nicolaides, K.H.: Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks. Prenat. Diagn. 31(1), 66–74 (2011) Akolekar, R., Syngelaki, A., Sarquis, R., Zvanca, M., Nicolaides, K.H.: Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks. Prenat. Diagn. 31(1), 66–74 (2011)
12.
go back to reference Poon, L.C., Nicolaides, K.H.: Early prediction of preeclampsia. Obstet. Gynecol. Int. (2014) Poon, L.C., Nicolaides, K.H.: Early prediction of preeclampsia. Obstet. Gynecol. Int. (2014)
13.
go back to reference Tan, M.Y., Syngelaki, A., Poon, L.C., Rolnik, D.L., O’Gorman, N., Delgado, J.L., et al.: Screening for pre-eclampsia by maternal factors and biomarkers at 11–13weeks’ gestation. Ultrasound Obstet. Gynecol. 52, 186–195 (2018)CrossRef Tan, M.Y., Syngelaki, A., Poon, L.C., Rolnik, D.L., O’Gorman, N., Delgado, J.L., et al.: Screening for pre-eclampsia by maternal factors and biomarkers at 11–13weeks’ gestation. Ultrasound Obstet. Gynecol. 52, 186–195 (2018)CrossRef
14.
go back to reference Tan, M.Y., Wright, D., Syngelaki, A., Akolekar, R., Cicero, S., Janga, D., et al.: Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE. Ultrasound Obstet. Gynecol. 51, 743–750 (2018)CrossRef Tan, M.Y., Wright, D., Syngelaki, A., Akolekar, R., Cicero, S., Janga, D., et al.: Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE. Ultrasound Obstet. Gynecol. 51, 743–750 (2018)CrossRef
15.
go back to reference Lindahl, C., Wagner, S., Uldbjerg, N., Schlütter, J.M., Bertelsen, O., Sandager, P.: Effects of context-aware patient guidance on blood pressure selfmeasurement adherence levels. Health Inform. J. 25(2), 417–428 (2019) Lindahl, C., Wagner, S., Uldbjerg, N., Schlütter, J.M., Bertelsen, O., Sandager, P.: Effects of context-aware patient guidance on blood pressure selfmeasurement adherence levels. Health Inform. J. 25(2), 417–428 (2019)
16.
go back to reference Sandager, P., Lindahl, C., Schlütter, J., Uldbjerg, N., Wagner, S., Toftegaard, T., et al.: Context-aware patient guidance during blood pressure self-measurement. In: Proceedings of the IADIS International Conference E-Health (2013) Sandager, P., Lindahl, C., Schlütter, J., Uldbjerg, N., Wagner, S., Toftegaard, T., et al.: Context-aware patient guidance during blood pressure self-measurement. In: Proceedings of the IADIS International Conference E-Health (2013)
Metadata
Title
A Time Study for the Analysis of the Potential for the Automated Stepwise Screening Program for Preeclampsia at Week 12 of Gestation
Authors
Louise Pedersen
Stefan Wagner
Henriette Skov
Puk Sandager
Copyright Year
2023
DOI
https://doi.org/10.1007/978-3-031-29548-5_13

Premium Partner